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Cigarette smoke is considered a major risk factor for vascular diseases. There are many toxic compounds in
cigarette smoke, including acrolein and other a,b-unsaturated aldehydes, which are regarded as mediators
of inﬂammation and vascular dysfunction. Furthermore, recent studies have revealed that acrolein, an a,b-
unsaturated aldehyde in cigarette smoke, induces inﬂammatory mediator expression, which is known to
be related to vascular diseases. In this study, we investigated whether Korean Red Ginseng (KRG) water
extract suppressed acrolein-induced cyclooxygenase (COX)-2 expression in human umbilical vein endo-
thelial cells (HUVECs). Acrolein-induced COX-2 expression was accompanied by increased levels of
phosphorylated p38 in HUVECs and KRG inhibited COX-2 expression in HUVECs. These results suggest that
KRG suppresses acrolein-induced COX-2 expression via inhibition of the p38 mitogen-activated protein
kinase signaling pathway. In addition, KRG exhibited an inhibitory effect on acrolein-induced apoptosis, as
demonstrated by annexin Vepropidium iodide staining and terminal deoxynucleotidyl transferase-
mediated dUTP nick end-labeling assay. Consistent with these results, KRG may exert a vasculoprotective
effect through inhibition of COX-2 expression in acrolein-stimulated human endothelial cells.
opyright  2013, The Korean Society of Ginseng, Published by Elsevier. Open access under CC BY-NC-ND license. 1. Introduction
Cigarette smoke (CS) is associated with the development of
inﬂammation-related diseases such as chronic obstructive pulmo-
nary disease and vascular diseases, including atherosclerosis and
stroke [1,2]. Several studies have revealed that CS is a major
contributor to vascular diseases because it accelerates the devel-
opment of atherosclerotic plaques [3,4]. The relationship between
CS and the increased incidence of atherosclerosis has been reported
[5e7], which may be a consequence of direct endothelial damage,
increased proliferation of smooth muscle in atherosclerotic lesions,
and/or decreased vasodilation [8].
Endothelial damage has also been suggested as the initial cause
of development of vascular diseases. In a previous study, it was
shown that inhibition of oxidative stress exerts protection in hu-
man endothelial cells, which could be an effective strategy in the
treatment of vascular diseases [9]. A number of studies support that
reactive oxygen species (ROS) causing oxidative stress may play an
essential role inmediating endothelial cell death. Oxidative stress is
a major factor in vascular diseases such as hypertension, stroke, andgy, School of Medicine, Kyung Hee
Ginseng, Published by Elsevier. Opeatherosclerosis. Several studies have reported that a,b-unsaturated
aldehyde acrolein in CS induces intracellular ROS generation
[10,11]. An increase in intracellular ROS levels causes cellular
dysfunction.
Korean Red Ginseng (KRG) is a popular traditional herbal
medicine that has been widely used to treat several diseases such
as cancer and vascular diseases. Recent research shows that
ginseng may have therapeutic potential in the treatment of Alz-
heimer’s disease, diabetes, cancer, and cardiovascular diseases,
through its antioxidant, antithrombotic, antihyperlipidemic, and
anticancer effects [12e15]. In endothelial cells, KRG simulates NO
production in vivo and in vitro, suggesting that KRG has antihy-
pertensive effects [16,17]. KRG also promotes angiogenesis through
the activation of the signaling pathway, indicating that KRG can be
implicated in potential angiogenic therapies for improving tissue
repair, wound healing, and cardiovascular diseases [18]. In addi-
tion, our previous study suggested that KRG exerts a cytopro-
tective effect through the induction of heme oxygenase (HO)-1
expression, suggesting a possible therapeutic mechanism of KRG
in cardiovascular diseases [19].University, Seoul 130-701, Korea.
n access under CC BY-NC-ND license. 
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pathogenesis of many human diseases such as atherosclerosis.
Accumulating evidence suggests that KRG is involved in the regula-
tion of inﬂammatory responses [20,21], suggesting an anti-inﬂam-
matory effect of KRG. Cyclooxygenase (COX) catalyzes the conversion
of arachidonic acid to prostaglandins that play vital roles in multiple
physiological and pathophysiological processes, including inﬂam-
mation. There are twodistinct isoformsof COX inmammalian cells. In
particular, COX-2 is normally undetectable in most tissues and is
induced in response to numerous stimuli. Vascular diseases may, in
part, be caused by COX-2 upregulation at sites of inﬂammation and
vascular injury. COX-2 plays an important role in inﬂammation,
therefore, inhibition of COX-2 expression may participate in the
treatmentof inﬂammation-relateddiseases such as vascular diseases.
The objective of our study was to investigate the vascular pro-
tective effect of KRG in acrolein-stimulated human umbilical vein
endothelial cells (HUVECs). Therefore, we examined the involve-
ment of COX-2 expression via p38mitogen-activated protein kinase
(MAPK), intracellular ROS, and apoptosis in acrolein-stimulated
HUVECs.
2. Materials and methods
2.1. Materials
KRG powder was obtained from the Korea Ginseng Corporation
(Daejeon, Korea). M199 medium and fetal bovine serum were
purchased from Welgene (Daegu, Korea). TRIzol reagent was sup-
plied by Invitrogen (Carlsbad, CA, USA). All other chemicals and
reagents were of analytical grade.
2.2. Preparation of KRG water extract
For preparation of KRGwater extract, wemodiﬁed amethod used
inaprevious study [22]. KRGpowderwassoaked inwater (1:25,w/w)
for 3 h, and boiled for 40min. Following centrifugation at 1,900 g for
60 min, supernatants of ginseng extract were further centrifuged at
10,000 g for 30min and lyophilized. Ginseng extracts were dissolved
in pure water immediately prior to the experiment. The general
composition of the product offered by the Korea Ginseng Corporation
is as follows:moisture 36%, solid volume64%, ash 2.5%, total fat 0.05%,
total crude saponin 70 mg/g, and total ginsenosides 20 mg/g.
2.3. Cell culture
HUVECs were maintained in M199 medium and supplemented
with 10% fetal bovine serum, 1% penicillin and streptomycin, 10 ng/
mL human ﬁbroblast growth factor, and 18 mU/mL heparin. The
cells were incubated at 37C under a 5% CO2 atmosphere. HUVECs
were grown to w80% conﬂuence, maintained with fresh medium
described above, and subcultured every 2 or 3 d. The cells were
used within nine passages during these experiments [23].
2.4. Western blot analysis
We applied 20 or 40 mg of the whole cell lysate proteins to each
lane and analyzed them with western blotting. Western blotting
was performed using primary antibodies as follows: anti-COX-2,
p38 MAPK, phopho-p38, cyclic AMP-responsive element-binding
protein (CREB), phospho-CREB (Cell Signaling, Danvers, MA, USA)
and anti-glyceraldehyde 3-phosphate dehydrogenase (AbFrontier,
Seoul, Korea). Horseradish-peroxidase-conjugated anti-IgG anti-
bodies were used as the secondary antibody to detect the above-
mentioned protein bands by enhanced chemiluminescence
WESTSAVE-Up (Abfrontier).2.5. RNA isolation and reverse transcriptase-polymerase chain
reaction
RNA extractionwas achieved using 1mLTRIzol reagent. The RNA
pelletswerewashed in 70% ethanol, dried completely, and dissolved
in diethylpyrocarbonate to inhibit RNase. Total RNA was quantiﬁed
using a ND-100 spectrometer (NanoDrop Technologies, Wilming-
ton, DE, USA). Polymerase chain reaction (PCR)was performedusing
the synthesized cDNA as a template and using speciﬁc primers for
COX-2 or b-actin as a loading control. The primer sequence for hu-
man COX-2was 50-GACAGTCCACCAACTTACAAT-30 (forward) and 50-
CATCTCTCCATCAATTATCTGAT-30 (reverse). The ampliﬁed products
were resolved by 1% agarose gel electrophoresis, stained with
ethidium bromide, and photographed under ultraviolet light.
2.6. Immunoﬂuorescence staining
HUVECs were cultured in a glass culture chamber slide (Falcon
Plastics, London Ontario, Canada) and processed for immunoﬂuo-
rescence analysis. Immunoﬂuorescence was performed as
described previously [24].
2.7. Measurement of prostaglandin E2
The amount of prostaglandin (PG)E2 in the culture mediumwas
measured using the PGE2 EIA kit according to the manufacturer’s
protocol (Cayman Chemical Company, Ann Arbor, MI, USA). Sam-
ples as well as standards were applied to a 96-well plate, precoated
with goat anti-mouse IgG, and incubated with PGE2 acetylcholin-
esterase tracer and PGE2 antiserum. All the wells were emptied,
rinsed ﬁve times, and incubatedwith Ellman’s reagent for 60min in
the dark with gentle rocking to produce 5-thio-2-nitrobenzoic acid,
which has a strong absorbance at 405 nm; the plate was read at
405 nm in an enzyme-linked immunosorbent assay reader (EL 800;
Bio-Tek, Winooski, VT, USA). We calculated the results using the
standard curve, which were expressed as picograms per milliliter.
2.8. Measurement of intracellular ROS generation
Intracellular ROS in acrolein-stimulated HUVECs is analyzed
using a ﬂuorescent dye, 20,70-dichloroﬂuorescein diacetate (DCF/
DA). In the presence of oxidants, DCFH was converted to the highly
ﬂuorescent DCF. After 18 h incubation with 25 mM acrolein in the
presence or absence of KRG, cells were stained with 10 mMDCF/DA,
and ﬂuorescence was analyzed by a FACS Vantage ﬂow cytometer
(Becton Dickinson, San Jose, CA, USA) and ﬂuorescence microscopy
(Eclipse 50i; Nikon, Japan) [25].
2.9. Terminal deoxynucleotidyl transferase-mediated dUTP nick
end-labeling assay
To clarify whether KRG-mediated inhibition of acrolein-
induced COX-2 expression plays a signiﬁcant role in cytoprotection
against oxidative stress, acrolein-stimulated cells were pretreated
with KRG (1 mg/mL) or untreated, and cell death was measured by
in situ terminal transferase dUTP nick end labeling (TUNEL) assay.
To measure DNA fragmentation, the commercially available in situ
death detection kit (Roche Diagnostics, Mannheim, Germany) was
utilized. HUVECs were cultured in a glass culture chamber slide
and ﬁxed for 30 min in 10% neutral buffered formalin solution at
room temperature. A TUNEL assay system was used, according to
the manufacturer’s instructions, for examination under a ﬂuores-
cence microscope, with excitation at 488 nm and emission at
525 nm [26].
Fig. 2. Inhibition of PGE2 secretion by KRG in acrolein-stimulated HUVECs. After
pretreatment with various concentrations of KRG (1 and 2 mg/mL) in 25 mM acrolein-
stimulated HUVECs for 18 h, the release of PGE2 was measured in the supernatants.
The values shown for PGE2 production are mean  standard deviation of three inde-
pendent experiments. *p < 0.001. HUVECs, human umbilical vein endothelial cells;
KRG, Korean Red Ginseng; PGE2, prostaglandin E2.
J Ginseng Res 2014;38:34e39362.10. Apoptosis assay
Cell death was detected by annexin Veﬂuorescein isothiocya-
nate (FITC) (BD PharMingen, San Diego, CA, USA) and propidium
iodide (PI) staining of necrotic and apoptotic cells. Cells were
washed in PBS, resuspended in 100 mL binding buffer containing
5 mL annexin VeFITC and 1 mg/mL PI, and incubated for 10 min at
room temperature in the dark. Cells were analyzed using a FACScan
(Becton Dickinson). Data were analyzed using CELLQuest software
(Becton Dickinson). Positioning of quadrants on the Annexin V/PI
dot plots was performed as previously described [25].
2.11. Statistical analysis
Data were expressed as mean  standard deviation. Statistical
analysis was performed using one-way analysis of variance
(GraphPad Prism version 4; GraphPad Software, San Diego, CA,
USA) followed by Bonferroni’s multiple comparison test.
3. Results
3.1. Effects of COX-2 inhibition by KRG in acrolein-stimulated
HUVECs
Upregulation of COX-2 expression plays a key role in inﬂam-
mation. A previous study found that acrolein in CS induces COX-2
expression in human endothelial cells [24]. We demonstrated the
effect of KRG on COX-2 induction in acrolein-stimulated HUVECs.
KRG inhibited acrolein-induced COX-2 protein expression in a
concentration-dependent manner (Fig. 1A). KRG also inhibited the
COX2 mRNA level (Fig. 1B).
3.2. Immunoﬂuorescence staining of COX-2
After pretreatment of acrolein-stimulated cells with KRG, the
cells were ﬁxed, and COX-2 localization in HUVECs was observed
by immunoﬂuorescence staining with an anti-COX-2 antibody
followed by a ﬂuorescence-tagged secondary antibody. Immu-
noﬂuorescence analysis showed that acrolein-induced COX-2
protein levels were inhibited in HUVECs after treatment with
KRG (Fig. 1C).Fig. 1. Inhibition of COX-2 by KRG in acrolein-stimulated HUVECs. Cell lysates were prepare
HUVECs for 18 h (protein) or 1 h (total RNA). COX-2 was determined by western blotting (A)
on 1% agarose gel (B). Representative data from 3 independent experiments are shown. CO
antibody followed by a ﬂuorescent-tagged secondary antibody (C). COX-2, cyclooxygenase-3.3. Inhibition of PGE2 secretion by KRG in acrolein-stimulated
HUVECs
The induction of COX-2 expression is known to be responsible for
PGE2 release in the culturemediumof cells stimulatedwith acrolein.
Acrolein increased PGE2 secretion, which was dramatically reduced
by KRG (Fig. 2). This result indicates that KRG leads to the reduction
of COX-2 protein expression and subsequently PGE2 biosynthesis in
acrolein-stimulated HUVECs.
3.4. Protection against acrolein-mediated oxidative stress provided
by KRG
Elevation of intracellular ROS levels causes cellular dysfunction.
Thus, we examined the effect of KRG on ROS production in acrolein-
stimulated cells. The shift to the right of the curve due to increased
ﬂuorescence indicates an increase in the intracellular levels of ROS.d after pretreatment with various concentrations of KRG in 25 mM acrolein-stimulated
. The ampliﬁed reverse transcriptase polymerase chain reaction product was visualized
X-2 localization was determined by immunoﬂuorescence staining with an anti-COX-2
2; HUVECs, human umbilical vein endothelial cells; KRG, Korean Red Ginseng.
Fig. 4. Central role of p38 and CREB signaling pathway in KRG-mediated inhibition of COX-2 expression in acrolein-stimulated cells. Cells were pretreated with KRG (1 and 2 mg/
mL) in 25 mM acrolein-stimulated HUVECs. Whole cell lysates were prepared and subjected to western blot analysis with antibodies against anti-phosph-p38 (A) and CREB (B).
Representative western blots of three independent experiments are shown. COX-2, cyclooxygenase-2; CREB, cyclic AMP-responsive element-binding protein; HUVECs, human
umbilical vein endothelial cells; KRG, Korean Red Ginseng.
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acrolein increased compared to untreated cells, whereas KRG
inhibited acrolein-induced ROS generation (Fig. 3A and B). These
results indicate that KRG may play a role in the inhibition of COX-2
expression via reduction of acrolein-generated ROS in acrolein-
stimulated HUVECs.
3.5. Involvement of p38 MAPKeCREB pathways in the inhibition of
acrolein-induced COX-2 expression by KRG
A previous study demonstrated that acrolein induces COX-2
expression via the p38 MAPKeCREB pathway [24]. Thus, to
determine the upstream signaling pathway involved in KRG-
mediated COX-2 inhibition, we measured the activation of p38
and CREB by detecting increased phospho-p38 and phospho-CREB
levels in acrolein-stimulated cells and found that phosphorylationFig. 3. Modulation of intracellular ROS generation by KRG in acrolein-stimulated HUVECs.
ﬂuorescence probe DCF. The curves correspond to cells cultured in the presence of vehicle (c
acrolein-stimulated cells (black line) (A). Cells were exposed to vehicle, 25 mM acrolein, an
ﬂuorescence microscopy (B). DCF, 20 ,70-dichloroﬂuorescein; HUVECs, human umbilical vein
pretation of the references to color in this ﬁgure legend, the reader is referred to the webof p38 and CREB was strongly reduced by KRG in acrolein-stim-
ulated cells (Fig. 4). These results demonstrate the role of p38 and
CREB signaling in the inhibition of acrolein-mediated COX-2
induction.
3.6. Inhibition of endothelial cell death by KRG in acrolein-
stimulated cells
Fluorescence-activated cell sorting showed thatwhile the number
of apoptotic cells increased following treatment with acrolein, pre-
treatmentwithKRGreduced thenumberof apoptotic cells (Fig. 5A). To
conﬁrm this result, we evaluated the presence of dead cells by TUNEL
staining,which iswidelyused indetectingDNA fragmentations in situ.
The TUNEL assay indicates cell death, including apoptosis, by detec-
tion of the appearance of intensely stained nuclei, which indicates
incorporation of labeled dUTP into the 30-end of fragmented DNAROS levels as measured by ﬂuorescence-activated cell sorting after staining with the
ontrol: green line), 25 mM acrolein treatment (red area), and pretreatment with KRG in
d 25 mM acrolein þ 1 mg/mL KRG in the presence of DCF diacetate and measured by
endothelial cells; KRG, Korean Red Ginseng; ROS, reactive oxygen species. (For inter-
version of this article.)
Fig. 5. Effect of KRG on apoptosis in acrolein-stimulated HUVECs. Acrolein (25 mM)-stimulated HUVECs were pretreated for 1 h with 1 mg/mL KRG. After 18 h incubation, the
protective effect of KRG on acrolein-induced apoptosis in HUVECs was determined by Annexin V/PI staining (A) and the in situ terminal transferase dUTP nick end labeling assay (B).
Quantitative data are presented as the fold of dead cells after treatment with annexin V/PI staining. Results are expressed as a dot plot and represent three independent exper-
iments. *p < 0.001. HUVECs, human umbilical vein endothelial cells; KRG, Korean Red Ginseng; PI, propidium iodide.
J Ginseng Res 2014;38:34e3938derived from apoptotic nuclei. As illustrated in Fig. 5B, acrolein
treatment signiﬁcantly increased the proportion of TUNEL-positive
cells,whichwas restoredbyKRGpretreatment. These results revealed
that the vascular protective effect of KRG ismediated by the inhibition
of COX-2 expression in acrolein-stimulated HUVECs.
4. Discussion
In this study, we explored the inhibition of an inﬂammatory
mediator, COX-2, by KRG water extract in HUVECs. We found that
KRG inhibited both mRNA and the protein level of COX-2 and its
cytoprotective effect in acrolein-stimulated HUVECs.
There is increasing evidence that a,b-unsaturated aldehydes in
CS, including acrolein and crotonaldehyde play an important
pathophysiological role in vascular diseases such as atherosclerosis
and Alzheimer’s disease. Exposure to a,b-unsaturated aldehydes is
critical to the inﬂammatory response via activation of the proin-
ﬂammatory signaling pathway and redox-sensitive transcription
factors [27,28]. Furthermore, a,b-unsaturated aldehydes increase
oxidative stress [29], which plays a crucial role in the pathogenesis
of vascular diseases via direct injury to the endothelium [30].
COX-2, a key enzyme for prostaglandin biosynthesis, is an
inducible enzyme that is rapidly induced during inﬂammatoryreactions. Numerous studies have reported the involvement of CS
in vascular diseases through COX-2 and endothelial NO synthase
activity [31,32]. Increase of COX-2 expression was reported to
promote atherosclerotic inﬂammation [33]. Chronic inﬂammation
plays an important role in vascular diseases, therefore, COX-2 may
participate in the development of inﬂammation-related diseases,
including vascular diseases.
Ginseng has been used as a general tonic for>2000 years in East
Asia, and it has become a famous herbal medicine for treatment of
various diseases, including vascular disorders. KRG has been re-
ported to have effective pharmacological activities, including
antioxidant, anticarcinogenic, and ameliorative effects on blood
circulation [34,35]. Recently, the diverse effects of several constit-
uents of KRG, including ginsenoside, on endothelial cells have been
extensively studied. Hien et al demonstrated the anti-inﬂammatory
and antiatherosclerotic activities of ginsenoside Rg3 in human
endothelial cells, with a decrease of cell adhesion molecules and
proinﬂammatory cytokines [36]. Moreover, the cytoprotective ef-
fect of ginsenoside Rb1 in endothelial cell damage mediated by
oxidized low-density lipoprotein has been reported [37]. Several
constituents of red ginseng have been reported to regulate prolif-
eration and migration and to protect oxidative stress-mediated
damage in human endothelial cells [38,39]. There is evidence
S.E. Lee and Y.S. Park / Inhibition of COX-2 by KRG 39demonstrating the presence of major ginsenosides including Rb1
and Rg1 in KRG water extract [40]. Thus, these components could
also contribute to the diverse retinue of protective actions of KRG.
A previous study showed that the induction of HO-1 expression
may exert protective effects in KRG-treated human endothelial cells
[19]. The inhibitoryeffectofKRGon inﬂammatory responseshas also
been reported. However, there have been no reports revealing the
mechanismunderlying KRG-inhibited COX-2 expression in acrolein,
a,b-unsaturated aldehydes in CS, stimulated HUVECs. We have
established that the major signaling pathway of COX-2 (i.e., p38
MAPKeCREB) and intracellular ROS generation are involved in this
inhibition of COX-2 expression in acrolein-stimulated HUVECs by
KRG. As mentioned above, KRG also exerts preventive effects on
apoptosis induced by acrolein. Therefore, the inhibition of COX-2
expression following KRG water extract treatment may be associ-
atedwith its strong protective effect in acrolein-stimulatedHUVECs.
In conclusion, we propose that the KRG water extract may exert
a cytoprotective effect through the inhibition of COX-2 induction
and that this reduction of COX-2 in acrolein-stimulated HUVECs is
mediated by the p38 MAPKeCREB pathway. This study suggests a
possible therapeutic mechanism of KRG in vascular diseases.
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